CME Course: Acting Rapidly – Step 2 in Hypertension Control Webinar

Target Audience:

Physicians, Nurse Practitioners, Nurses, Pharmacists, Physician Assistants, Medical Assistants, Clinical Care Staff, and Quality Improvement Staff

Description
This one-hour webinar will be used to train clinicians and other care team members registered for the AHA/AMA joint Target: BP™ initiative, on the “Act Rapidly” component of the AMA MAP™ framework. MAP stands for Measure Accurately, Act Rapidly, and Partner with Patients.

The goal of acting rapidly is to reduce therapeutic inertia and improve blood pressure in patients whose BP is uncontrolled. This is accomplished through a combination of using an evidence-based treatment protocol, using single-pill combination antihypertensive medications, team-based care, and following up frequently with patients until BP control is achieved.

The activity will include didactic instruction, interactive elements to apply learning, and practical tools and resources to assess and improve practice presented from a team-based perspective.

Learning Objectives 
At the completion of this course, the learner will be able to:

• Define therapeutic inertia and list contributing factors
• Describe impact and importance of treatment intensification, follow-up interval, and medication adherence strategies on improving blood pressure control
• Review strategies and resources to address therapeutic inertia and increase treatment intensification, including the use of combination antihypertensive medications

Course Agenda

Faculty
Kate Kirley, MD
Disease Prevention & Programs
Alison P. Smith, MPH, BA, BSN, RN
AMA/AHA Program Director
Klodiana Myftari, Pharm D
AMA, Director, Clinical Pharmacy Relationships
Rupi Hayer, MPH
AMA, Senior Program Manager
Allie Bateman, BS
AHA Senior Program Consultant

Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by the American Heart Association and the American Medical Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hours of Category I credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
**AMA Credit must be claimed within 6 months of attendance. Credit will no longer be available to claim after April 29, 2025.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 1.00contact hours.
**ANCC Credit must be claimed within 6 months of attendance. CE credit will no longer be available to claim after April 29, 2025.

ACPE Credit Designation Statement – Pharmacists
ACPE Credit: 1.00 Contact Hours.  Universal Program Number:  JA0000134-9999-24-069-L01-P
**ACPE Credit must be claimed within 30 days of participation. ACPE credit will no longer be available to claim after November 29, 2024.

Disclosures
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Medium
This activity is a live or a virtual link activity depending on the location.

Contact Information
For customer support contact 1-877-340-9899 (Monday-Friday, 8:00 am to 6:00 pm Central Standard Time) or email [email protected]

Policy on Privacy and Confidentiality:
Please see the privacy link at the bottom of the AHA Professional Education Hub.

Copyright Information
Please see the link at the bottom of the AHA Professional Education Hub.

Commercial Support
This activity did not receive independent medical educational grants.

Don't need CME/CE?

A recording of this webinar without continuing education is also available.

Watch Now